• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用免疫复合物组分析检测膀胱癌患者新型尿液标志物:初步研究。

Detection of Novel Urine Markers Using Immune Complexome Analysis in Bladder Cancer Patients: A Preliminary Study.

机构信息

Department of Pharmacy Practice, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

出版信息

In Vivo. 2021 Jul-Aug;35(4):2073-2080. doi: 10.21873/invivo.12476.

DOI:10.21873/invivo.12476
PMID:34182482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8286497/
Abstract

BACKGROUND/AIM: Little is known on urine biomarkers that are associated with malignant behavior in patients with bladder cancer (BC). Our aim was to identify BC-related factors in urine samples using our original method "immune complexome analysis", based on detecting the immune complex (IC).

PATIENTS AND METHODS

Immune complexome analysis was performed using urine samples from 97 BC patients, including 67 with non-muscle invasive BC (NMIBC).

RESULTS

Eight IC-antigens were recognized as candidates for BC-related factors from 20,165 proteins. IC-serum albumin, -fibrinogen γ chain, -hemoglobin subunit α, -hemoglobin subunit β, -ceruloplasmin, and fibrinogen β chain were significantly associated with either pathological features and/or outcome. IC-ceruloplasmin was most widely associated with pathological features in all BC patients and lamina propria invasion and urinary tract recurrence in NMIBC.

CONCLUSION

Based on detection of IC-antigens it was demonstrated that six IC-antigens, especially IC-ceruloplasmin, are potential urine biomarkers in BC.

摘要

背景/目的:膀胱癌(BC)患者的尿液生物标志物与恶性行为相关的信息知之甚少。我们的目的是使用我们的原始方法“免疫复合物组分析”,基于检测免疫复合物(IC),来鉴定尿液样本中的 BC 相关因素。

患者与方法

对 97 例 BC 患者的尿液样本进行了免疫复合物组分析,其中包括 67 例非肌肉浸润性 BC(NMIBC)患者。

结果

从 20165 种蛋白质中鉴定出 8 种 IC-抗原作为 BC 相关因素的候选物。IC-血清白蛋白、-纤维蛋白原γ链、-血红蛋白亚基α、-血红蛋白亚基β、-铜蓝蛋白和纤维蛋白原β链与病理特征和/或预后显著相关。IC-铜蓝蛋白与所有 BC 患者的病理特征以及 NMIBC 的固有层浸润和尿路复发最广泛相关。

结论

基于 IC-抗原的检测表明,六种 IC-抗原,特别是 IC-铜蓝蛋白,是 BC 潜在的尿液生物标志物。

相似文献

1
Detection of Novel Urine Markers Using Immune Complexome Analysis in Bladder Cancer Patients: A Preliminary Study.应用免疫复合物组分析检测膀胱癌患者新型尿液标志物:初步研究。
In Vivo. 2021 Jul-Aug;35(4):2073-2080. doi: 10.21873/invivo.12476.
2
Ceruloplasmin Levels in Cancer Tissues and Urine Are Significant Biomarkers of Pathological Features and Outcome in Bladder Cancer.癌组织和尿液中铜蓝蛋白水平是膀胱癌病理特征和预后的重要生物标志物。
Anticancer Res. 2021 Aug;41(8):3815-3823. doi: 10.21873/anticanres.15174.
3
Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.尿液中的无细胞长链非编码 RNA 表达特征可作为膀胱癌诊断和复发预测的新型无创生物标志物。
J Cell Mol Med. 2018 May;22(5):2838-2845. doi: 10.1111/jcmm.13578. Epub 2018 Mar 8.
4
Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.尿拓扑异构酶-IIA游离DNA在膀胱癌诊断中的价值
Investig Clin Urol. 2016 Mar;57(2):106-12. doi: 10.4111/icu.2016.57.2.106. Epub 2016 Mar 11.
5
Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.尿液外泌体长链非编码 RNA 的表达谱可作为膀胱癌诊断和复发预测的新型无创生物标志物。
Mol Cancer. 2018 Sep 29;17(1):142. doi: 10.1186/s12943-018-0893-y.
6
Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging.膀胱癌诊断和分期的尿液生物标志物的全面蛋白质组学和平台验证。
BMC Med. 2023 Apr 5;21(1):133. doi: 10.1186/s12916-023-02813-x.
7
A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.用于检测尿脱落细胞中非肌层浸润性膀胱癌(NMIBC)复发的甲基化检测。
BJU Int. 2012 Mar;109(6):941-8. doi: 10.1111/j.1464-410X.2011.10428.x. Epub 2011 Jul 14.
8
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.一项全面多中心研究中用于非肌层浸润性膀胱癌患者复发监测的新型、灵敏且特异的尿液检测方法的验证
Front Genet. 2019 Dec 18;10:1237. doi: 10.3389/fgene.2019.01237. eCollection 2019.
9
Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.一种用于膀胱癌监测的新型基于mRNA的尿液检测方法准确性提高。
BJU Int. 2018 Jan;121(1):29-37. doi: 10.1111/bju.14019. Epub 2017 Oct 12.
10
Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer.Xpert 膀胱癌监测仪在非肌肉浸润性膀胱癌患者随访中的诊断预测价值。
J Clin Pathol. 2019 Feb;72(2):140-144. doi: 10.1136/jclinpath-2018-205393. Epub 2018 Oct 24.

引用本文的文献

1
Plasma proteome fingerprint in kidney diseases.肾脏疾病中的血浆蛋白质组指纹图谱。
Front Mol Biosci. 2025 Jan 17;11:1494779. doi: 10.3389/fmolb.2024.1494779. eCollection 2024.
2
Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma.碳酸酐酶 IX(CA-IX)在膀胱尿路上皮癌中的表达及其预后价值。
BMC Urol. 2022 Aug 3;22(1):120. doi: 10.1186/s12894-022-01074-9.
3
Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis.基于免疫特征的膀胱癌相关免疫相关基因的鉴定及其与预后的相关性
Front Genet. 2021 Nov 26;12:763590. doi: 10.3389/fgene.2021.763590. eCollection 2021.

本文引用的文献

1
Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.长链非编码 RNA,ENST00000598996 和 ENST00000524265,与膀胱癌的良好预后相关,可作为潜在的肿瘤抑制因子。
Oncol Rep. 2020 Nov;44(5):1831-1850. doi: 10.3892/or.2020.7733. Epub 2020 Aug 13.
2
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients.免疫复合物组分析鉴定出与免疫球蛋白结合的生物标志物,这些标志物可预测胰腺癌患者对化疗的反应。
Cancers (Basel). 2020 Mar 21;12(3):746. doi: 10.3390/cancers12030746.
3
Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.基于两次连续 UroVysion 荧光原位杂交检测结果分层的膀胱癌膀胱内复发风险:日本的一项前瞻性随访研究。
Int J Clin Oncol. 2020 Jun;25(6):1163-1169. doi: 10.1007/s10147-020-01634-9. Epub 2020 Mar 3.
4
A novel tumor suppressing gene, , is an independent prognostic biomarker for bladder cancer.一种新型抑癌基因,是膀胱癌的独立预后生物标志物。 (注:原文中“,”处应补充具体基因名称)
Oncol Lett. 2020 Jan;19(1):476-486. doi: 10.3892/ol.2019.11123. Epub 2019 Nov 19.
5
Clinical significance of urinary plasminogen and fibrinogen gamma chain as novel potential diagnostic markers for non-small-cell lung cancer.尿纤溶酶原和纤维蛋白原 γ 链作为非小细胞肺癌新型潜在诊断标志物的临床意义。
Clin Chim Acta. 2020 Mar;502:55-65. doi: 10.1016/j.cca.2019.11.022. Epub 2019 Dec 9.
6
Value of immune factors for monitoring risk of lung cancer in patients with interstitial lung disease.免疫因子在监测间质性肺疾病患者肺癌风险中的价值。
J Int Med Res. 2019 Jul;47(7):3344-3353. doi: 10.1177/0300060519847403. Epub 2019 Jul 1.
7
Comprehensive immune complexome analysis detects disease-specific immune complex antigens in seminal plasma and follicular fluids derived from infertile men and women.全面免疫复合物组学分析可检测不育男性和女性的精液和卵泡液中具有疾病特异性的免疫复合物抗原。
Clin Chim Acta. 2019 Aug;495:545-551. doi: 10.1016/j.cca.2019.05.031. Epub 2019 May 31.
8
Prediction tools in non-muscle invasive bladder cancer.非肌层浸润性膀胱癌的预测工具
Transl Androl Urol. 2019 Feb;8(1):39-45. doi: 10.21037/tau.2019.01.15.
9
Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma.复发性霍奇金淋巴瘤儿童和青少年血浆生物标志物的蛋白质组学鉴定
J Cancer. 2018 Nov 24;9(24):4650-4658. doi: 10.7150/jca.27560. eCollection 2018.
10
Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer.术前中性粒细胞与淋巴细胞比值可改善非肌层浸润性膀胱癌的复发预测。
BMC Urol. 2018 Oct 22;18(1):90. doi: 10.1186/s12894-018-0404-x.